Title | Type | SJR | H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2006) | %Female (2006) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Biochemical Pharmacology | journal | 1.533 Q1 | 220 | 319 | 1357 | 16908 | 5632 | 1310 | 4.05 | 53.00 | 35.83 | |
52 | Tetrahedron | journal | 1.524 Q1 | 236 | 1309 | 3497 | 60611 | 10440 | 3480 | 2.95 | 46.30 | 27.61 | |
53 | Current Drug Targets | journal | 1.512 Q1 | 119 | 161 | 224 | 19288 | 997 | 205 | 4.41 | 119.80 | 29.90 | |
54 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.511 Q1 | 106 | 55 | 176 | 1629 | 527 | 174 | 2.77 | 29.62 | 33.19 | |
55 | Cancer Biology and Therapy | journal | 1.490 Q1 | 130 | 340 | 810 | 10059 | 1618 | 507 | 1.66 | 29.59 | 38.29 | |
56 | Drug Metabolism and Disposition | journal | 1.490 Q1 | 194 | 281 | 683 | 8936 | 3360 | 672 | 4.44 | 31.80 | 31.40 | |
57 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.464 Q1 | 108 | 47 | 137 | 4962 | 589 | 131 | 4.18 | 105.57 | 35.11 | |
58 | Particle and Fibre Toxicology | journal | 1.458 Q1 | 119 | 16 | 14 | 852 | 74 | 13 | 5.29 | 53.25 | 33.68 | |
59 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.446 Q1 | 99 | 24 | 48 | 3594 | 210 | 45 | 4.00 | 149.75 | 35.48 | |
60 | Current Opinion in Drug Discovery and Development | journal | 1.404 Q1 | 85 | 67 | 245 | 3875 | 1246 | 229 | 5.43 | 57.84 | 26.72 | |
61 | Toxicology and Applied Pharmacology | journal | 1.398 Q1 | 189 | 273 | 803 | 12287 | 3410 | 788 | 4.32 | 45.01 | 35.91 | |
62 | European Neuropsychopharmacology | journal | 1.382 Q1 | 130 | 91 | 258 | 4338 | 995 | 256 | 4.03 | 47.67 | 32.52 | |
63 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.377 Q1 | 150 | 225 | 478 | 10311 | 1848 | 467 | 3.21 | 45.83 | 33.49 | |
64 | Pharmacogenomics Journal | journal | 1.357 Q1 | 95 | 54 | 158 | 2304 | 673 | 139 | 4.74 | 42.67 | 31.32 | |
65 | Drug Safety | journal | 1.352 Q1 | 140 | 93 | 262 | 5283 | 1202 | 245 | 4.54 | 56.81 | 36.06 | |
66 | British Journal of Clinical Pharmacology, Supplement | journal | 1.331 Q1 | 33 | 0 | 18 | 0 | 60 | 17 | 1.00 | 0.00 | 0.00 | |
67 | Alcoholism: Clinical and Experimental Research | journal | 1.329 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
68 | Toxicological Sciences | journal | 1.327 Q1 | 207 | 333 | 894 | 14700 | 3449 | 860 | 3.83 | 44.14 | 36.42 | |
69 | Microbial Drug Resistance | journal | 1.319 Q1 | 78 | 47 | 169 | 1326 | 419 | 169 | 2.20 | 28.21 | 52.56 | |
70 | Tetrahedron Letters | journal | 1.314 Q1 | 181 | 1965 | 6158 | 57964 | 16635 | 6157 | 2.65 | 29.50 | 24.23 | |
71 | European Journal of Pharmaceutics and Biopharmaceutics | journal | 1.313 Q1 | 185 | 131 | 384 | 3603 | 1353 | 377 | 3.84 | 27.50 | 36.90 | |
72 | American Journal of Respiratory Medicine | journal | 1.279 Q1 | 34 | 0 | 42 | 0 | 173 | 42 | 0.00 | 0.00 | 0.00 | |
73 | Expert Opinion on Therapeutic Targets | journal | 1.268 Q1 | 106 | 84 | 204 | 7122 | 651 | 195 | 3.07 | 84.79 | 36.52 | |
74 | Current Gene Therapy | journal | 1.267 Q1 | 80 | 46 | 138 | 6424 | 615 | 134 | 4.49 | 139.65 | 35.11 | |
75 | Drug Discovery Today | journal | 1.251 Q1 | 215 | 161 | 1060 | 7603 | 3278 | 847 | 3.22 | 47.22 | 19.55 | |
76 | CNS Drug Reviews | journal | 1.246 Q1 | 64 | 19 | 72 | 1749 | 253 | 70 | 2.92 | 92.05 | 34.15 | |
77 | Chemical Research in Toxicology | journal | 1.244 Q1 | 177 | 208 | 610 | 9445 | 2222 | 604 | 3.54 | 45.41 | 31.93 | |
78 | Journal of Gene Medicine | journal | 1.242 Q1 | 100 | 135 | 418 | 5844 | 1765 | 415 | 4.25 | 43.29 | 33.89 | |
79 | Current Vascular Pharmacology | journal | 1.222 Q1 | 69 | 37 | 112 | 4751 | 422 | 109 | 4.05 | 128.41 | 28.43 | |
80 | Current Drug Targets: Inflammation and Allergy | journal | 1.209 Q1 | 53 | 0 | 172 | 0 | 620 | 159 | 3.62 | 0.00 | 0.00 | |
81 | Journal of Studies on Alcohol and Drugs | journal | 1.207 Q1 | 137 | 112 | 336 | 4124 | 897 | 323 | 2.19 | 36.82 | 48.06 | |
82 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 1.205 Q1 | 50 | 10 | 17 | 1137 | 75 | 17 | 4.41 | 113.70 | 24.53 | |
83 | Behavioural Pharmacology | journal | 1.197 Q1 | 87 | 75 | 214 | 3638 | 568 | 205 | 2.47 | 48.51 | 44.13 | |
84 | Pharmaceutical Research | journal | 1.197 Q1 | 229 | 280 | 808 | 11542 | 3096 | 803 | 3.59 | 41.22 | 29.86 | |
85 | Clinical Therapeutics | journal | 1.185 Q1 | 150 | 195 | 616 | 7159 | 2396 | 547 | 3.65 | 36.71 | 30.04 | |
86 | Journal of Psychopharmacology | journal | 1.183 Q1 | 135 | 144 | 275 | 6477 | 851 | 238 | 3.09 | 44.98 | 32.88 | |
87 | Journal of Natural Products | journal | 1.162 Q1 | 161 | 395 | 1195 | 9805 | 3306 | 1190 | 2.72 | 24.82 | 35.22 | |
88 | Receptors and Channels | journal | 1.143 Q1 | 44 | 0 | 59 | 0 | 169 | 56 | 2.53 | 0.00 | 0.00 | |
89 | Journal of Biomolecular Screening | journal | 1.140 Q1 | 86 | 103 | 218 | 2841 | 843 | 215 | 3.67 | 27.58 | 34.55 | |
90 | Antiviral Research | journal | 1.139 Q1 | 151 | 118 | 262 | 5565 | 980 | 260 | 3.40 | 47.16 | 37.55 | |
91 | Journal of Nanobiotechnology | journal | 1.124 Q1 | 109 | 14 | 27 | 465 | 106 | 27 | 4.33 | 33.21 | 32.14 | |
92 | Current Opinion in Investigational Drugs | journal | 1.120 Q1 | 83 | 132 | 484 | 7673 | 1527 | 446 | 3.01 | 58.13 | 23.96 | |
93 | Journal of Clinical Pharmacology | journal | 1.119 Q1 | 130 | 153 | 435 | 4640 | 1727 | 431 | 3.79 | 30.33 | 33.73 | |
94 | Addictive Behaviors | journal | 1.118 Q1 | 149 | 228 | 512 | 6951 | 1315 | 510 | 2.42 | 30.49 | 44.53 | |
95 | Toxicon | journal | 1.115 Q1 | 144 | 217 | 706 | 8412 | 1821 | 694 | 2.64 | 38.76 | 40.75 | |
96 | Journal of Pharmaceutical Sciences | journal | 1.088 Q1 | 206 | 243 | 781 | 7812 | 2399 | 761 | 2.92 | 32.15 | 29.12 | |
97 | Expert Opinion on Investigational Drugs | journal | 1.075 Q1 | 117 | 138 | 426 | 11102 | 1507 | 414 | 3.45 | 80.45 | 29.14 | |
98 | Molecular Pharmaceutics | journal | 1.074 Q1 | 156 | 82 | 119 | 3749 | 441 | 110 | 3.71 | 45.72 | 29.63 | |
99 | Investigational New Drugs | journal | 1.068 Q1 | 97 | 64 | 165 | 2161 | 577 | 162 | 3.27 | 33.77 | 31.39 | |
100 | European Journal of Pharmacology | journal | 1.060 Q1 | 203 | 754 | 2151 | 30523 | 6429 | 2141 | 2.86 | 40.48 | 34.55 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®